JPRN-UMIN000046806已完成未知
An evaluation of efficacy for blood flow and cold intolerance of test food intake. - A placebo-controlled, randomized, double-blind cross-over clinical trial - - An evaluation of efficacy for blood flow and cold intolerance of test food intake.
IMEQRD Co., Ltd0 个研究点目标入组 20 人开始时间: 2022年2月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Those who have been currently visiting a hospital or treated with any drug or herbal remedy for any disease 2.Those who are on diet/exercise therapy under the guidance of a doctor 3.Those who currently have or have history of severe diseases 4.Those who have serious anemia 5.Those who daily take medicine, quasi-medicine, food for specified health uses or nutritional supplements / foods on the market that have health claims related to fatigue, stress relief, cold intolerance, blood flow, blood pressure or calefacient (excluding individuals who can refrain from ingestion after receiving informed consent until the end of the study) 6.Those who are using any machine related to fatigue, stress relief, cold intolerance, blood flow, blood pressure or calefacient (excluding individuals who can refrain from the use after the informed consent until the end of the study) 7.Those who currently have or have a history of drug and/or food allergies 8.Those who have smoked within a year 9.Males who have donated more than 400 mL of the blood within 3 months before receiving informed consent 10.Females who have donated more than 200 mL of the blood within 3 months before receiving informed consent 11.Those who have plans of major change on their lifestyle (e.g., diet, sleep and exercise) during the study period 12.Those who have daily exercise such as jogging and muscle training 13.Those who are engaged in night work or spilt shift 14.Those who are planning to travel abroad during the study period 15.Those who are currently pregnant, breastfeeding or planning to get pregnant during the study period. 16.Those who joined other clinical trials since 1 month before receiving informed consent in this study, or those who are currently joining other clinical trials 17.Those who are judged by the physician to be unsuitable for this study.
研究者
相似试验
进行中（未招募）
不适用
Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonaryEUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40
已完成
不适用
A study for improving effects on the blood flow and the skin by carbonate cosmeticsHealthy adultsJPRN-UMIN000025658Kao Corporation40
已完成
不适用
Clinical investigation into efficacy, haemodynamics and tolerability of simvastatin versus placebo in patients with pulmonary arterial hypertensioPulmonary hypertensionCirculatory SystemOther pulmonary heart diseasesISRCTN27178415niversity Hospital Giessen (Germany)40
已完成
不适用
A study to examine the effects of blood flow improvement and body temperature maintenance effectsHealthy IndividualsJPRN-UMIN000039180Medicial Corporation Kenshokai, Fukushima Healthcare Center36
招募中
3 期
comparative study on the increase of blood flow velocity and administration of oral activated charcoal on the severity of uremic pruritus in hemodialysis patientsIRCT20180807040729N1Shahroud University of Medical Sciences60